IMPORTANT CONFERENCE UPDATE!
Our conference venue is a 30 minute walk from the site of the incidents, therefore our show is on as scheduled today. We have received update that local airports, Amtrak and T-Stations are open and on schedule. Please email us at firstname.lastname@example.org if you have any questions.
With outsourcing on the rise, the FDA and regulatory agencies worldwide are focusing greater attention on product quality. Regulatory agencies from the FDA to ANVISA are heavily scrutinizing where Active Pharmaceutical Ingredients are coming from as the level of oversight increases. Furthermore, a number of large pharmaceutical companies recently have lost billions of dollars when faced with consent decrees. Are you confident that GMP standards are being met throughout the manufacturing process? Can you afford the cost of a consent decree?
ExL Pharma’s 3rd CMO Quality Oversight and Risk Management Conference is the premier event for gaining best practice strategies to effectively oversee and manage CMOs. Hear from key leaders at big pharma companies as well as pharma contract manufacturing service providers to find out how risk is being managed on both the sponsor and vendor sides, while quality is ensured through robust quality agreements and compliance with multiple GMP standards.
New for 2013:
“This conference exceeded expectations due to interaction and conversation between presenters and attendees.”
– Brian Eater, QA Manager, Kadmon Pharmaceutical
“The event exceeded what I expected. I gained a wealth of valuable information. All speakers both days were very knowledgeable of their subject matter.”
– Linda Colle, Customer Quality Engineer, Hospira
This conference is designed for representatives from pharmaceutical, biotechnology, and medical device companies with responsibilities in the following areas: